TranS1 Inc. Announces Participation at the 2012 Lazard Capital Markets Healthcare Conference 

TranS1 Inc. Announces Participation at the 2012 Lazard Capital Markets Healthcare Conference

WILMINGTON, N.C., Nov 1, 2012 (Menafn - GlobeNewswire via COMTEX) --TranS1 Inc. TSON announced today that Ken Reali, President and Chief Executive Officer, and Joe Slattery, Executive Vice President and Chief Financial Officer, are scheduled to present at the 2012 Lazard Capital Markets Healthcare Conference in New York, NY on Wednesday, November 14, 2012 at 11:30 am ET. Institutional investors that wish to request a meeting with TranS1 should contact Lazard Capital Markets.

About TranS1 Inc.

TranS1 is a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF(R) family of products for single and two level lumbar fusion, the VEO(TM) lateral access and interbody fusion system and the Vectre(TM) posterior fixation system for lumbar fixation supplemental to AxiaLIF fusion. TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina. For more information, visit www.trans1.com.

This news release was distributed by GlobeNewswire, www.globenewswire.com

SOURCE: TranS1 Inc.

CONTACT: Investors:
TranS1 Inc.
Joseph P. Slattery, 910-332-1700
Executive Vice-President and Chief Financial Officer
Westwicke Partners
Mark Klausner, 443-213-0501
trans1@westwicke.com

(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.